Pennsylvania became the 38th state to pass a “right-to-try” law earlier this month, enacting legislation that aims to increase access by terminal patients to investigational therapies that have cleared Phase…
The European Medicines Agency launched a new plan to streamline procedures for developing advanced gene and cell therapies, including adapting manufacturing requirements to products’ specific challenges. Source: Drug Industry Daily
CAR-T therapy is the big thing right now, with this week's approval of Gilead Yescarta and the recent approval of Novartis' Kymriah. Source: BioSpace
Universal Cells will get $9 million upfront and is eligible to regulatory milestones payments of up to $115 million, as well as royalties. Source: BioSpace
DURECT's Posimir (SABER - Bupivacaine) for post-surgical pain failed its Phase III clinical trial. Source: BioSpace
Allergan is a good example of how many mergers and acquisitions over a very short period of time created a large, international company. Source: BioSpace
Analysts with SunTrust Robinson Humphrey recently published a research report that looked at a number of large-cap pharma companies. Source: BioSpace
The way the university handled it violated state law, according to state officials. Source: BioSpace
Two factors have increased speculation that Smith & Nephew may be ready for a takeover. Source: BioSpace
This IMPD has been submitted through the EMA clinical trial portal for approval prior to opening of clinical centers in France. Source: BioSpace